1Institute of Sports Science, Seoul National University, Seoul, Korea
2School of Physical Education, Xizang Minzu University, Xianyang, China
3Institute of Sports Biology, Shaanxi Normal University, Xi’an, China
4Institute on Aging, Seoul National University, Seoul, Korea
Copyright © 2021 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported.
AUTHOR CONTRIBUTIONS
Conception or design: D.Z., W.S.
Acquisition, analysis, or interpretation of data: D.Z., J.H.L., H.E.S., S.E.K.
Drafting the work or revising: D.Z., J.H.L., H.E.S., S.E.K., J.H.B., L.T., W.S.
Final approval of the manuscript: W.S.
FUNDING
This work was supported by the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning (2020M3A9D803866011), Korea Mouse Phenotyping Project (2013M3A9D5072550, 2013M3A9D5072560) and the National Natural Science Foundation of China (grant no. 82060422).
Variable |
Diet |
Exercise |
Diet×exercise |
|||
---|---|---|---|---|---|---|
F | P value | F | P value | F | P value | |
BW, g | 1.644 | 0.218 | 16.61 | 0.001b | 0.257 | 0.620 |
AUC for energy intake | 29.17 | 0.001b | 20.42 | 0.002b | 0.984 | 0.350 |
Fat mass from body composition analysis, g | 0.140 | 0.714 | 9.670 | 0.067 | 0.350 | 0.563 |
Adipose tissue mass, g | ||||||
iWAT | 56.03 | <0.001b | 10.58 | 0.005b | 2.094 | 0.167 |
eWAT | 5.676 | 0.030b | 2.532 | 0.131 | 1.022 | 0.327 |
iBAT | 1.972 | 0.179 | 6.582 | 0.021b | 0.047 | 0.832 |
Normalized adipose tissue mass, mg/g | ||||||
iWAT/BW | 63.32 | <0.001b | 0.515 | 0.483 | 0.789 | 0.387 |
eWAT/BW | 1.721 | 0.207 | 0.001 | 0.971 | 0.188 | 0.670 |
iBAT/BW | 5.80 | 0.028b | 2.175 | 0.159 | 0.081 | 0.779 |
Fasting blood glucose, mg/dL | 24.48 | <0.001b | 1.746 | 0.205 | 0.261 | 0.616 |
AUC of ipGTT | 11.43 | 0.004b | 13.43 | 0.002b | 9.495 | 0.007b |
Serum TC | 41.00 | <0.001b | 6.160 | 0.018b | 2.593 | 0.090b |
Serum TG | 3.857 | 0.031b | 9.321 | 0.005b | 0.349 | 0.708 |
QUAD TG | 4.244 | 0.031b | 3.755 | 0.069 | 3.841 | 0.041b |
Normalized skeletal muscle mass, mg/g | ||||||
QUAD/BW | 73.67 | <0.001b | 2.135 | 0.153 | 1.603 | 0.216 |
GAS/BW | 54.74 | <0.001b | 0.001 | 0.981 | 1.236 | 0.303 |
TA/BW | 115.6 | <0.001b | 0.707 | 0.405 | 1.040 | 0.364 |
SOL/BW | 12.49 | <0.001b | 7.092 | 0.008b | 0.329 | 0.722 |
EDL/BW | 3.153 | 0.055 | 2.183 | 0.149 | 2.474 | 0.099 |
Hanging time (sec)×BW(kg) | 0.525 | 0.480 | 27.87 | <0.001b | 1.272 | 0.277 |
Grip strength (g)/BW(kg) | 0.211 | 0.652 | 9.440 | 0.007b | 0.993 | 0.334 |
Autophagy-related proteins | ||||||
LC3I | 14.49 | <0.001b | 2.877 | 0.105 | 1.137 | 0.340 |
LC3II | 4.877 | 0.018b | 21.39 | 0.001b | 3.517 | 0.048b |
LC3II/LC3I ratio | 6.512 | 0.006b | 6.642 | 0.018b | 2.528 | 0.104 |
P62 | 4.189 | 0.028b | 1.742 | 0.200 | 0.943 | 0.404 |
BNIP3 | 0.843 | 0.445 | 6.079 | 0.022b | 1.860 | 0.180 |
Beclin1 | 4.385 | 0.024b | 0.017 | 0.899 | 2.587 | 0.096 |
Glucose metabolism | ||||||
p-AMPK/AMPK ratio | 0.499 | 0.614 | 7.387 | 0.013b | 2.487 | 0.106 |
p-mTOR/mTOR ratio | 11.51 | 0.001b | 3.000 | 0.095 | 0.555 | 0.580 |
GLUT4 | 8.250 | 0.002b | 5.249 | 0.032b | 0.280 | 0.758 |
Mitochondria metabolism | ||||||
PGC1α | 2.632 | 0.094 | 8.683 | 0.007b | 0.224 | 0.801 |
Myogenesis | ||||||
MyoD | 5.478 | 0.011b | 8.916 | 0.007b | 0.739 | 0.489 |
BW, body weight; AUC, area under the curve; iWAT, inguinal white adipose tissue; eWAT, epididymal white adipose tissue; iBAT, interscapular brown adipose tissue; ipGTT, intraperitoneal glucose tolerance test; TC, total cholesterol; TG, triglyceride; QUAD, quadriceps; GAS, gastrocnemius; TA, tibialis anterior; SOL, soleus; EDL, extensor digitorum longus; LC3, microtubule-associated proteins 1A/1B light chain 3; BNIP3, BCL2 interacting protein 3; AMPK, AMP-activated protein kinase; mTOR, mechanistic target of rapamycin; GLUT4, glucose transporter type 4; PGC1α, peroxisome proliferator-activated receptor γ coactivator-1α; MyoD, myogenic differentiation.
a P values for diet, exercise, and their combined effect (diet×exercise) were analyzed by two-way analysis of variance,
b P<0.05.
Variable | Diet |
Exercise |
Diet×exercise |
|||
---|---|---|---|---|---|---|
F | P value | F | P value | F | P value | |
BW, g | 1.644 | 0.218 | 16.61 | 0.001 |
0.257 | 0.620 |
AUC for energy intake | 29.17 | 0.001 |
20.42 | 0.002 |
0.984 | 0.350 |
Fat mass from body composition analysis, g | 0.140 | 0.714 | 9.670 | 0.067 | 0.350 | 0.563 |
Adipose tissue mass, g | ||||||
iWAT | 56.03 | <0.001 |
10.58 | 0.005 |
2.094 | 0.167 |
eWAT | 5.676 | 0.030 |
2.532 | 0.131 | 1.022 | 0.327 |
iBAT | 1.972 | 0.179 | 6.582 | 0.021 |
0.047 | 0.832 |
Normalized adipose tissue mass, mg/g | ||||||
iWAT/BW | 63.32 | <0.001 |
0.515 | 0.483 | 0.789 | 0.387 |
eWAT/BW | 1.721 | 0.207 | 0.001 | 0.971 | 0.188 | 0.670 |
iBAT/BW | 5.80 | 0.028 |
2.175 | 0.159 | 0.081 | 0.779 |
Fasting blood glucose, mg/dL | 24.48 | <0.001 |
1.746 | 0.205 | 0.261 | 0.616 |
AUC of ipGTT | 11.43 | 0.004 |
13.43 | 0.002 |
9.495 | 0.007 |
Serum TC | 41.00 | <0.001 |
6.160 | 0.018 |
2.593 | 0.090 |
Serum TG | 3.857 | 0.031 |
9.321 | 0.005 |
0.349 | 0.708 |
QUAD TG | 4.244 | 0.031 |
3.755 | 0.069 | 3.841 | 0.041 |
Normalized skeletal muscle mass, mg/g | ||||||
QUAD/BW | 73.67 | <0.001 |
2.135 | 0.153 | 1.603 | 0.216 |
GAS/BW | 54.74 | <0.001 |
0.001 | 0.981 | 1.236 | 0.303 |
TA/BW | 115.6 | <0.001 |
0.707 | 0.405 | 1.040 | 0.364 |
SOL/BW | 12.49 | <0.001 |
7.092 | 0.008 |
0.329 | 0.722 |
EDL/BW | 3.153 | 0.055 | 2.183 | 0.149 | 2.474 | 0.099 |
Hanging time (sec)×BW(kg) | 0.525 | 0.480 | 27.87 | <0.001 |
1.272 | 0.277 |
Grip strength (g)/BW(kg) | 0.211 | 0.652 | 9.440 | 0.007 |
0.993 | 0.334 |
Autophagy-related proteins | ||||||
LC3I | 14.49 | <0.001 |
2.877 | 0.105 | 1.137 | 0.340 |
LC3II | 4.877 | 0.018 |
21.39 | 0.001 |
3.517 | 0.048 |
LC3II/LC3I ratio | 6.512 | 0.006 |
6.642 | 0.018 |
2.528 | 0.104 |
P62 | 4.189 | 0.028 |
1.742 | 0.200 | 0.943 | 0.404 |
BNIP3 | 0.843 | 0.445 | 6.079 | 0.022 |
1.860 | 0.180 |
Beclin1 | 4.385 | 0.024 |
0.017 | 0.899 | 2.587 | 0.096 |
Glucose metabolism | ||||||
p-AMPK/AMPK ratio | 0.499 | 0.614 | 7.387 | 0.013 |
2.487 | 0.106 |
p-mTOR/mTOR ratio | 11.51 | 0.001 |
3.000 | 0.095 | 0.555 | 0.580 |
GLUT4 | 8.250 | 0.002 |
5.249 | 0.032 |
0.280 | 0.758 |
Mitochondria metabolism | ||||||
PGC1α | 2.632 | 0.094 | 8.683 | 0.007 |
0.224 | 0.801 |
Myogenesis | ||||||
MyoD | 5.478 | 0.011 |
8.916 | 0.007 |
0.739 | 0.489 |
BW, body weight; AUC, area under the curve; iWAT, inguinal white adipose tissue; eWAT, epididymal white adipose tissue; iBAT, interscapular brown adipose tissue; ipGTT, intraperitoneal glucose tolerance test; TC, total cholesterol; TG, triglyceride; QUAD, quadriceps; GAS, gastrocnemius; TA, tibialis anterior; SOL, soleus; EDL, extensor digitorum longus; LC3, microtubule-associated proteins 1A/1B light chain 3; BNIP3, BCL2 interacting protein 3; AMPK, AMP-activated protein kinase; mTOR, mechanistic target of rapamycin; GLUT4, glucose transporter type 4; PGC1α, peroxisome proliferator-activated receptor γ coactivator-1α; MyoD, myogenic differentiation.